Madrigal Pharmaceuticals, Inc.

MDGL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$482.00+3.14%

2026-08-03

Financials

Valuation Metrics

Madrigal Pharmaceuticals, Inc.'s Market Cap is $11.11B. At end of 2025 it was $13.06B. Ranked #892 of 3,112 in US market (top 29%), #279 of 1,445 on NASDAQ (top 19%), #41 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 15%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$11.11B	US#892/3,112 Sec#41/269
Revenue	$1.28B	US#1,787/3,112 Sec#48/269
Net Income	$-325M	US—/3,112 Sec—/269
Total Assets	$1.24B	US#2,345/3,112 Sec#85/269
Net Assets	$524M	US#2,220/3,112 Sec#108/269
Value
P/B	21.22x	US#2,825/3,112 Sec#237/269
P/S	8.66x	US#2,600/3,112 Sec#113/269
FCF Yield	-1.86%	US—/3,112 Sec—/269
Profitability
ROE	-62.07%	US#2,780/3,112 Sec#191/269
ROA	-26.12%	US#2,835/3,112 Sec#147/269
Op. Margin	-25.13%	US#2,719/3,112 Sec#108/269
Revenue Growth	71.17%	US#204/3,112 Sec#42/269
Financial Health
Debt Ratio	137.65%	US#1,406/3,112 Sec#180/269
Total Debt	$348M	US#1,985/3,112 Sec#68/269
FCF	$-206M	US#2,738/3,112 Sec#219/269
Cash	$293M	US#1,446/3,112 Sec#82/269
Current Ratio	3.20x	US#741/3,112 Sec#188/269
Performance
1Y Return	59.51%	US#676/3,112 Sec#113/269
1M Return	-8.73%	US#2,528/3,112 Sec#154/269
From 52W High	-21.63%	US#1,793/3,112 Sec#118/269
1Y MDD	-29.36%	US#1,331/3,112 Sec#84/269
Trading
Volume	423,119 shares	US#2,181/3,112 Sec#212/269
Trading Value	$202M	US#523/3,112 Sec#29/269
Per Share
EPS	$-12.85	US—/3,112 Sec—/269
BPS	$26.86	US#956/3,112 Sec#21/269